Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Incyte Corporation    INCY   US45337C1027

INCYTE CORPORATION (INCY)

17
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on INCYTE CORPORATION
7d ago INCYTE : Assigned Patent
04/16 INCYTE : to Report First Quarter 2014 Financial Results on May 1
04/14 INCYTE : Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte,..
04/11DJRiding the Tech Roller Coaster -2-
04/11DJRiding the Tech Roller Coaster
04/11 INCYTE : Assigned Patent
03/28 As U.S. momentum stocks take beating, some sectors benefit
03/25 INCYTE : Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharm..
03/24 MID CAP LOSERS : Incyte Corporation (NASDAQ:INCY), Tableau Software (NYSE:DATA),..
03/12 INCYTE CORPORATION : Incyte Reports Positive Top-Line Results from Phase III Stu..
03/10 INCYTE CORP : Change in Directors or Principal Officers (form 8-K)
03/07 INCYTE CORPORATION : Incyte Announces Positive Top-Line Results from Phase III S..
02/21 INCYTE CORPORATION : INCYTE CORP - 10-K - Management's Discussion and Analysis o..
02/21 INCYTE CORPORATION : Incyte to Present at Upcoming Investor Conferences
02/18 INCYTE CORPORATION : Incyte to Present at Upcoming Investor Conferences
02/12 INCYTE CORPORATION : Incyte Announces Clinical Trial Collaboration with Merck to..
02/12 INCYTE CORPORATION : INCYTE CORP FILES (8-K) Disclosing Results of Operations an..
02/12 INCYTE CORPORATION : Incyte Reports 2013 Fourth-Quarter and Year-End Financial R..
02/05 Merck results flag, but cancer-drug deals lift shares
02/05DJMerck in Pacts to Study Cancer Treatment
02/05DJMerck Profit Falls 14% on Sales Drop; Confirms Collaborations on Investigatio..
02/05 INCYTE CORPORATION : Incyte Announces Clinical Trial Collaboration with Merck to..
01/31 INCYTE CORPORATION : Incyte Assigned Patent
01/27 INCYTE CORPORATION : Incyte to Report Fourth Quarter/Year-End 2013 Financial Res..
01/24 INCYTE CORPORATION : INCYTE CORP FILES (8-K) Disclosing Change in Directors or P..
01/22 NOVARTIS AG : Incyte Names Herve Hoppenot President and Chief Executive Officer
01/14 INCYTE CORPORATION : Incyte Reports Inducement Grant Under NASDAQ Listing Rule 5..
01/13 INCYTE CORPORATION : INCYTE CORP FILES (8-K) Disclosing Change in Directors or P..
01/13 INCYTE CORPORATION : Incyte Assigned Patent
01/13 INCYTE CORPORATION : Incyte Names Hervé Hoppenot President and CEO
01/13 INCYTE CORPORATION : Incyte Names Hervé Hoppenot President and Chief Executive O..
01/08 INCYTE CORPORATION : Patent Issued for Methods of Diagnosing Pancreatic Inflamma..
2013 INCYTE CORPORATION : Incyte to Present at the 32nd Annual J. P. Morgan Healthcar..
2013 INCYTE CORPORATION : Incyte to Present at the 32nd Annual J. P. Morgan Healthcar..
2013 INCYTE CORPORATION : Incyte to Present at the 32nd Annual J. P. Morgan Healthcar..
2013 INCYTE CORPORATION : Incyte to Present at the 32nd Annual J. P. Morgan Healthcar..
2013 INCYTE CORPORATION : Incyte Joins Speakers at the 32nd Annual J. P. Morgan Healt..
2013 INCYTE CORPORATION : Incyte Participates in 2013 ASH
2013 INCYTE CORPORATION : Incyte to Present at the 32nd Annual J. P. Morgan Healthcar..
2013 INCYTE CORPORATION : Incyte Releases Positive Results from Proof-of-Concept Phas..
2013 INCYTE CORPORATION : Incyte Reports Jakafi (ruxolitinib) Continues to Show Impro..
2013 INCYTE CORPORATION : Incyte Participates in 2013 ASH
2013 INCYTE CORPORATION : Jakafi Presents Data at American Society of Hematology Meet..
2013 INCYTE CORPORATION : CURE Magazine and Incyte Laud Inaugural MPN Heroes
2013 INCYTE CORPORATION : CURE Magazine and Incyte Recognize Inaugural MPN Heroes
2013 INCYTE CORPORATION : Updated Financial Standings, Company Announcements, and Upc..
2013 INCYTE CORPORATION : Positive Results Presented from Proof-of-Concept Phase II C..
2013 INCYTE CORPORATION : Incyte Reports Jakafi Data Continues to Show Improved Overa..
2013 INCYTE CORPORATION : Jakafi® (ruxolitinib) Continues to Show Improved Overall Su..
2013 INCYTE CORPORATION : Jakafi® (ruxolitinib) Continues to Show Improved Overall Su..
2013 INCYTE CORPORATION : Incyte to Present at the Oppenheimer 24th Annual Healthcare..
2013 INCYTE CORPORATION : Incyte to Present at the Oppenheimer 24th Annual Healthcare..
2013 Boston Biomedical Appoints Patricia S. Andrews as Chief Commercial Officer
2013 INCYTE CORPORATION : Boston Biomedical Appoints Patricia S. Andrews as Chief Com..
2013 DAINIPPON SUMITOMO PHARMA CO LTD : Boston Biomedical Names Patricia S. Andrews a..
2013 Boston Biomedical Names Patricia S. Andrews as Chief Commercial Officer
2013 Incyte Makes Commitment to Delaware with 15-year Lease
2013 INCYTE CORPORATION : Incyte Makes Commitment to Delaware with 15-year Lease
2013DJJANUS CAPITAL MANAGEMENT 3Q 13F : Largest Sales -2-
2013DJJANUS CAPITAL MANAGEMENT 3Q 13F : Largest Sales
2013DJJANUS CAPITAL MANAGEMENT 3Q 13F : Holdings As Of -2-
2013DJJANUS CAPITAL MANAGEMENT 3Q 13F : Holdings As Of Sep 30
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : -2-
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Eliminations
2013DJMILLENNIUM MANAGEMENT 3Q 13F : Largest Purchases -2-
2013DJMILLENNIUM MANAGEMENT 3Q 13F : Largest Purchases
2013DJMILLENNIUM MANAGEMENT 3Q 13F : Holdings As Of Sep -2-
2013DJMILLENNIUM MANAGEMENT 3Q 13F : Holdings As Of Sep 30
2013 INCYTE CORP FILES (8-K) Disclosing Entry into a Material Definitive Agreement..
2013 INCYTE CORPORATION : INCYTE CORP FILES (8-K) Disclosing Entry into a Material De..
2013 Incyte Completes Offering of $750M of Convertible Senior Notes
2013 INCYTE CORPORATION : Incyte Completes Offering of $750M of Convertible Senior No..
2013 INCYTE CORPORATION : Incyte Completes Offering of $750 Million of Convertible Se..
2013DJTHE VANGUARD GROUP 3Q 13F : Largest Purchases -2-
2013DJTHE VANGUARD GROUP 3Q 13F : Largest Purchases
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Incyte Corporation Technical Analysis Chart | INCY | US45337C1027 | 4-Traders
Income Statement Evolution
Incyte Corporation : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF